Jessie Xie > Hogan Lovells International LLP > Chaoyang District, China > Lawyer Profile

Hogan Lovells International LLP
7th Floor, Tower 3
China Central Place
No. 77 Jianguo Road
Beijing 100025
China
Jessie Xie photo

Work Department

Corporate

Position

Counsel

Career

As a seasoned member in our Life Science and Health Care group, Jessie Xie has developed her practice to cover all types of regulatory work in the medical device, pharmaceutical, health care, food, and cosmetic industry sectors in China. She believes that the goal is not always to answer the question, but to help you achieve a competitive advantage and minimize regulatory risk.

Jessie is familiar with product approval, clinical trials, adverse event report, product recalls, labelling, advertising requirements, as well as compliance with Chinese laws and regulations relating to local manufacturing and global distribution of medical devices, drugs, food, and cosmetic.

She has worked with multinational medical device and pharmaceutical companies to spot regulatory risks, prevent problems from happening, and resolve them in a practical manner. Jessie has also worked with foreign universities to develop cooperative research programs in China, and has helped health care companies with the establishment of jointly operated hospitals. Jessie also advises extensively on privacy, data protection, encryption, commercial franchising, and direct selling practice – the areas that are rapidly changing and highly regulated in China.

Languages

English, Chinese (Mandarin)

Education

LL.M., University of Aberdeen, 2006

LL.B., Guizhou University, 2004

Lawyer Rankings

China > Life sciences and healthcare: foreign firms

(Leading associates)

Jessie XieHogan Lovells International LLP

Leveraging its lawyers’ experience as government officials in regulatory and policy agencies, Hogan Lovells International LLP‘s Greater China life sciences practice is consistently sought out to for complex regulatory issues. The team advises at all stages of life sciences products, from initial clinical trials to off-patent strategy, business development and defence-side litigation The team also advises on new technology-driven areas, such as digital health, AI, gene therapy and regenerative medicine. On the mainland, Lu Zhou advises life sciences and healthcare clients on cross-border transactions; and Calvin Ding represents companies (and their board committees) in relation to corruption, conflicts of interest, trade compliance and cybersecurity incidents. Jessie Xie‘s practice covers regulatory work and commercial contracts in the pharmaceutical, medical devices, healthcare, food, and cosmetics sectors.